Laboratory & Imaging Assessment
Help characterize atherosclerosis, plaque burden, insulin resistance, hepatic steatosis (MASLD), fibrosis risk, and metabolic or endocrine changes during the menopausal transition—informing risk stratification and intervention priorities.
Note: Physical examinations, testing, imaging, and medical care are provided by qualified third-party institutions or licensed professionals where applicable. Arclect supports health record management, pathway planning, and preparation for medical discussions.
Body Composition & Physical Function Assessment
Continuous Metabolic & Health Behavior Monitoring
Establish baseline, stratify risk, and define priorities through clinical biomarkers, functional assessment, and continuous metabolic and behavioral tracking.
VO₂max, grip strength, lean mass, and bone mineral density decline with age and are associated with cardiovascular risk, all-cause mortality, cognitive decline, metabolic dysfunction, sarcopenia, osteoporosis, and fracture risk. These assessments help identify functional reserve and healthspan-related risks that routine testing may not capture.
Postprandial glucose excursions, dietary patterns, physical activity, sleep, and recovery interact with insulin resistance, lipids, blood pressure, and long-term cardiometabolic risk. The analysis can reveal triggers and modifiable patterns that cross-sectional testing may miss.
Advanced Laboratory Markers｜Liver Fat Quantification |
Vascular Imaging Assessment
Whole-Body DXA Scan｜Cardiopulmonary Exercise Testing |
Grip Strength Assessment
Continuous Glucose Monitoring | Sleep & Recovery Assessment |
Dietary Intake & Physical Activity Analysis
Integrated Analysis & Risk Stratification Report
Findings are synthesized to establish a baseline physiological profile, inform risk stratification, and delineate clinical priorities for intervention planning.
